A detailed history of Perigon Wealth Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 92,464 shares of JNJ stock, worth $14.3 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
92,464
Previous 89,472 3.34%
Holding current value
$14.3 Million
Previous $13.1 Million 14.58%
% of portfolio
0.41%
Previous 0.38%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$145.48 - $167.38 $435,276 - $500,800
2,992 Added 3.34%
92,464 $15 Million
Q2 2024

Aug 02, 2024

SELL
$144.38 - $157.78 $1.41 Million - $1.54 Million
-9,759 Reduced 9.83%
89,472 $13.1 Million
Q1 2024

Apr 29, 2024

SELL
$155.22 - $162.74 $2.78 Million - $2.92 Million
-17,918 Reduced 15.3%
99,231 $15.7 Million
Q4 2023

Jan 29, 2024

BUY
$145.6 - $158.88 $2.92 Million - $3.19 Million
20,065 Added 20.67%
117,149 $18.4 Million
Q3 2023

Oct 30, 2023

SELL
$155.75 - $174.48 $965,027 - $1.08 Million
-6,196 Reduced 6.0%
97,084 $15.1 Million
Q2 2023

Aug 02, 2023

BUY
$154.35 - $166.11 $6.32 Million - $6.81 Million
40,975 Added 65.77%
103,280 $17.1 Million
Q1 2023

May 03, 2023

SELL
$151.05 - $180.26 $98,484 - $117,529
-652 Reduced 1.04%
62,305 $9.66 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $1.98 Million - $2.22 Million
12,361 Added 24.43%
62,957 $11.1 Million
Q3 2022

Dec 13, 2022

BUY
$161.33 - $179.52 $596,114 - $663,326
3,695 Added 7.88%
50,596 $8.27 Million
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $255,816 - $282,921
1,521 Added 3.35%
46,901 $8.33 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $201,944 - $229,336
1,277 Added 2.9%
45,380 $8.04 Million
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $500,535 - $555,362
3,210 Added 7.85%
44,103 $7.55 Million
Q3 2021

Nov 01, 2021

BUY
$161.5 - $179.47 $6.13 Million - $6.81 Million
37,948 Added 1288.56%
40,893 $6.6 Million
Q3 2021

Oct 25, 2021

SELL
$161.5 - $179.47 $6.12 Million - $6.8 Million
-37,872 Reduced 92.78%
2,945 $476,000
Q2 2021

Jul 19, 2021

BUY
$159.48 - $171.07 $3,349 - $3,592
21 Added 0.05%
40,817 $6.72 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $617,331 - $687,545
4,033 Added 10.97%
40,796 $6.71 Million
Q4 2020

Jan 28, 2021

SELL
$137.11 - $157.38 $157,813 - $181,144
-1,151 Reduced 3.04%
36,763 $5.79 Million
Q3 2020

Nov 03, 2020

SELL
$140.38 - $153.83 $148,241 - $162,444
-1,056 Reduced 2.71%
37,914 $5.65 Million
Q2 2020

Jul 29, 2020

BUY
$128.81 - $155.51 $150,836 - $182,102
1,171 Added 3.1%
38,970 $5.48 Million
Q1 2020

Apr 17, 2020

BUY
$111.14 - $153.99 $728,856 - $1.01 Million
6,558 Added 20.99%
37,799 $5.34 Million
Q4 2019

Jan 13, 2020

SELL
$127.5 - $146.44 $278,587 - $319,971
-2,185 Reduced 6.54%
31,241 $4.5 Million
Q3 2019

Oct 25, 2019

SELL
$126.95 - $142.14 $834,188 - $934,001
-6,571 Reduced 16.43%
33,426 $4.44 Million
Q2 2019

Aug 05, 2019

SELL
$131.15 - $144.24 $440,795 - $484,790
-3,361 Reduced 7.75%
39,997 $5.57 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $1.07 Million - $1.19 Million
-8,499 Reduced 16.39%
43,358 $6.06 Million
Q4 2018

Feb 11, 2019

BUY
$122.84 - $147.84 $1.48 Million - $1.78 Million
12,060 Added 30.3%
51,857 $6.27 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $145,531 - $171,027
1,197 Added 3.1%
39,797 $5.5 Million
Q2 2018

Aug 09, 2018

BUY
$119.4 - $131.76 $480,585 - $530,334
4,025 Added 11.64%
38,600 $4.68 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $65,552 - $77,625
524 Added 1.54%
34,575 $4.43 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $399,171 - $436,892
-3,042 Reduced 8.2%
34,051 $4.76 Million
Q3 2017

Dec 05, 2017

SELL
$129.47 - $135.38 $2.73 Million - $2.86 Million
-21,115 Reduced 36.28%
37,093 $4.82 Million
Q2 2017

Sep 12, 2017

BUY
N/A
58,208 New
58,208 $7.7 Million
Q3 2011

Nov 14, 2022

BUY
N/A
3,695
50,596 $8.27 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.